Evaluate CRDF stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in CRDF? | Glauxie AI

Q: What are the risks of investing in CRDF?

Cardiff Oncology, Inc. (CRDF) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Mani Mohindru. Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1... Employees: 31.

Q: How much debt does CRDF have?

Review CRDF total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is CRDF a good long-term investment?

Evaluate CRDF as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in CRDF?

🦉

Cardiff Oncology, Inc. (CRDF)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMani Mohindru

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase...

Key Executives

Name	Title
Ajay Aggarwal	Chief Operating Officer
Brigitte Lindsay	Chief Accounting Officer
Elizabeth Anderson	Vice President of Finance & Administration
Josh Muntner	Chief Financial Officer
Mani Mohindru	President, CEO & Director
Roger Sidhu	Chief Medical Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

CRDF Profile Financials

Is CRDF stock safe? How much debt does CRDF have? Is CRDF a good long-term investment?